Arrowhead Pharmaceuticals Inc. (ARWR) Reports Q2 EPS of $0.45
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $83.99 +4.41%
Revenue Growth %: +89.8%
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
More
Revenue Growth %: +89.8%
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q2 EPS of $0.45, versus $0.41 reported last year. Revenue for the quarter came in at $146.3 million, versus $151.8 million reported last year.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- FactSet Research Systems (FDS) PT Raised to $253 at Jefferies
- H.C. Wainwright Reiterates Buy Rating on Arrowhead Pharma (ARWR)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
